Moreover, recent data suggest that increased serum concentrations of IL-13 are seemingly correlated to severe COVID-19 outcomes and IL-13 blockade reduced disease severity in a mouse model of SARS-CoV2 infection (73). Here, IL13 is linked to COVID-19.